Literature DB >> 1164876

[Prevention of postoperative thrombo-embolism using a new principle of drug treatment (author's transl)].

G Buttermann, W Theisinger, H Oechsler, G Hör.   

Abstract

Slowing of venous return is, in addition to endothelial damage and hypercoagulability, one of the decisive factors in the development of thrombi. This is especially so in operated patients with loss of vessel tone caused by general anaesthesia. The radiofibrinogen test was used on a group of 106 patients to check whether the administration of dihydroergotamine, which produces vasoconstriction particularly of the venous channels, can bring about a reduction in the incidence of postoperative thrombo-embolism. There was a statistically (variance analysis) highly significant difference in the average thrombosis rate between treated (8.8%) and untreated (34.7%) patients. In patients especially at risk, the rate was more than three times as high in the untreated group (39.5% and 12.9%, respectively). In low-risk patients the rate actually dropped to zero (from 20%).

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1164876     DOI: 10.1055/s-0028-1106501

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  3 in total

1.  Interspecies similarities in the disposition of 3H-dihydroergotamine following subcutaneous administration in man and rabbits.

Authors:  F L Tse; J M Jaffe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jan-Mar       Impact factor: 2.441

2.  The pharmacokinetics of subcutaneous dihydroergotamine with and without a dextran 70 infusion.

Authors:  B Lindblad; E Abisch; D Bergqvist
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  Clinical pharmacokinetics of heparin.

Authors:  J W Estes
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.